Biofrontera
BFRIW
4 hedge funds and large institutions have $35.2K invested in Biofrontera in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.
0.05% less ownership
Funds ownership: 1.25% → 1.2% (-0.05%)
20% less funds holding
Funds holding: 5 → 4 (-1)
57% less capital invested
Capital invested by funds: $81.8K → $35.2K (-$46.6K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$3.3K |
| 2 |
CS
Clear Street
New York
|
-$64 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BA
1
Bard Associates
Chicago,
Illinois
| $22.1K | – | – | – |
|
2
Osaic Holdings
Scottsdale,
Arizona
| $11.8K | – | – | – |
|
|
CS
3
Clear Street
New York
| $1.16K | -$64 | -399 | -4% |
|
4
US Bancorp
Minneapolis,
Minnesota
| $110 | – | – | – |
|
|
5
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$3.3K | -13,485 | Closed |
|
BFRIW Hedge Fund Activity: Q2 2023 in Review
4 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Biofrontera (BFRIW) for Q2 2023, worth a combined $35.2K — down 57% from $81.8K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of BFRIW and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.
The largest seller was Susquehanna International Group, exiting entirely with an estimated $3.3K sold.
- 4 institutional investors held Biofrontera (BFRIW) as of Q2 2023, down from 5 in Q1 2023.
- Funds reported $35.2K of Biofrontera stock for Q2 2023, down 57% quarter-over-quarter.
- 0 funds opened new Biofrontera positions in Q2 2023 and 1 closed out, a net change of -1 holder.
- The largest Biofrontera seller in Q2 2023 was Susquehanna International Group, an estimated $3.3K sold.
Based on aggregated 13F filings for Q2 2023.